Brady W Dougan sold $6.6M of HUMA
director at Humacyte, Inc.. 1,500,000 shares at an average of $4.40, traded Nov 18, 2024, filed Nov 20, 2024.
Score components
- +15RoleDirector
- +25Trade size$6.6M at market
- +10Share of holdings soldSold 46% of holdings
- +8Cluster2 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +5.2%, 3m -12.2%, 6m -46.9%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001818382-24-000206, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 18, 2024 | SOpen-market sale Common Stockindirect: By Ayabudge LLC | -811,172 | $4.44 | $3.6M | 2,419,712 | Nov 20, 2024 |
| Nov 19, 2024 | SOpen-market sale Common Stockindirect: By Ayabudge LLC | -427,459 | $4.34 | $1.9M | 1,992,253 | Nov 20, 2024 |
| Nov 20, 2024 | SOpen-market sale Common Stockindirect: By Ayabudge LLC | -261,369 | $4.40 | $1.2M | 1,730,884 | Nov 20, 2024 |
Related signals
Other insiders at Humacyte, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 21Weak | HUMAbuy Humacyte, Inc. | Keith Anthony Jones director | $5,620 10,000 shares | +25% | |
| 51Moderate | Humacyte, Inc. | Michael T. Constantino director | $20k 16,000 shares | +94% | |
| 51Moderate | Humacyte, Inc. | Charles Bruce Green director | $7,740 6,000 shares | +250% | |
| 21Weak | HUMAbuy Humacyte, Inc. | Michael T. Constantino director | $20k 4,600 shares | +37% | |
| 18Weak | Humacyte, Inc. | Brady W Dougan director | $7,979 1,797 shares | +1% | |
| 28Weak | Humacyte, Inc. | Laura E Niklason President, CEO and Director | $7,979 1,797 shares | +1% | |
| 68Notable | Humacyte, Inc. | Laura E Niklason President, CEO and Director | $6.6M 1,500,000 shares | -46% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.